Qube Research & Technologies LTD Oncorus, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.85 - $1.65 $1,700 - $3,300
-2,000 Reduced 11.19%
15,874 $13,000
Q2 2022

Aug 15, 2022
BUY
$1.04 - $1.86 $18,588 - $33,245
17,874 New
17,874 $23,000
Q2 2021

Aug 13, 2021
SELL
$13.3 - $17.3 $168,271 - $218,879
-12,652 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$11.89 - $35.55 $150,432 - $449,778
12,652 New
12,652 $176,000

About Oncorus, Inc.

ONCR Quotes by TradingView
  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email